Zinc ribbon domain containing 1 protein: Modulator of multidrug resistance, tumorigenesis and cell cycle

Experimental Oncology

Volumn 28, Issue 4, 2006, Pages 258-262

  Hong, L ^a   Han, Y ^a   Chen, Z ^a   Zhang, X ^a   Xia, L ^a   Han, Z ^a   Lu, Y ^a   Jin, H ^a   Song, J ^a   Qiao, T ^a   Fan, D ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Gastric cancer; Multidrug resistance; ZNRD1

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; INOSINATE DEHYDROGENASE; INOSINATE DEHYDROGENASE INHIBITOR; METHOTREXATE; PROTEIN; UNCLASSIFIED DRUG; VERAPAMIL; VINCRISTINE; ZINC RIBBON DOMAIN CONTAINING 1 PROTEIN;

APOPTOSIS; CARCINOGENESIS; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE REGULATION; DNA REPAIR; DRUG ACCUMULATION; DRUG RETENTION; DRUG SENSITIVITY; GENE LOCUS; GENETIC TRANSCRIPTION; HLA SYSTEM; HUMAN; LEUKEMIA; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STOMACH CANCER; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; DNA REPAIR; DNA-BINDING PROTEINS; DRUG RESISTANCE, MULTIPLE; HUMANS;

EID: 33846893471     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Fan W, Wang Z, Kyzysztof F, Prange C, Lennon G. A new zinc ribbon gene (ZNRD1) is cloned from the human MHC class I region. Genomics 2000; 63: 139-41.
2. Schimanski B, Brandenburg J, Nguyen TN, Caimano MJ, Gunzl A. A TFIIB-like protein is indispensable for spliced leader RNA gene transcription in Trypanosoma brucei. Nucleic Acids Res 2006; 34: 1676-84.
3. Tubon TC, Tansey WP, Herr W. A nonconserved surface of the TFIIB zinc ribbon domain plays a direct role in RNA polymerase II recruitment. Mol Cell Biol 2004; 24: 2863-74.
4. Bushnell DA, Westover KD, Davis RE, Kornberg RD. Structural basis of transcription: an RNA polymerase II-TFIIB cocrystal at 4.5 Angstroms. Science 2004; 303: 983-8.
5. Qian X, Jeon C, Yoon H, Agarwal K, Weiss MA. Structure of a new nucleic - acid - binding motif in eukaryotic transcriptional elongation factor TFIIS. Nature 1993; 365: 277-9.
6. Hansen G, Harrenga A, Wieland B, Schomburg D, Reinemer P. Crystal structure of full length topoisomerase I from Thermotoga maritima. J Mol Biol 2006; 358: 1328-40.
7. Okuda M, Tanaka A, Hanaoka F, Ohkuma Y, Nishimura Y. Structural insights into the asymmetric effects of zinc-ligand cysteine mutations in the novel zinc ribbon domain of human TFIIEalpha for transcription. J Biochem 2005; 138: 443-9.
8. Fan D, Zhang X, Chen X, Mou Z, Hu J, Zhou S, Ding J, Wu K. Bird's-eye view on gastric cancer research of the past 25 years. J Gastroenterol Hepatol 2005; 20: 360-5.
9. Penuelas S, Noe V, Ciudad CJ. Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells. FEBS J 2005; 272: 696-710.
10. Abdul-Ghani R, Serra V, Gyorffy B. The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1. Oncogene 2006; 25: 1743-52.
11. Takahashi S, Ito Y, Hatake K, Sugimoto Y. Gene therapy for breast cancer. Review of clinical gene therapy trials for breast cancer and MDR1 gene therapy trial in Cancer Institute Hospital. Breast Cancer 2006; 13: 8-15.
12. Frelet A, Klein M. Insight in eukaryotic ABC transporter function by mutation analysis. FEBS Lett 2006; 580: 1064-84.
13. Zhao Y, You H, Liu F. Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett 2002; 185: 211-8.
14. Hong L, Piao Y, Han Y, Wang J, Zhang X, Du Y, Cao S, Qiao T, Chen Z, Fan D. ZNRD1 mediates multidrug resistance of leukemia cells through regulation of P-gp and Bcl-2. Zinc ribbon domain-containing 1 (ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2. Mol Cancer Ther 2005; 4: 1936-42.
15. Piao Y, Chen X, Liu L, Hong L. Reversion of multidgug resistance in HL-60/VCR cells by down-regulation of bcl-2 with bcl-2 siRNA. Zhongguo Shi Van Xue Ye Xue Za Zhi 2005; 13: 1010-3.
16. Hong L, Ning X, Shi Y, Shen H, Zhang Y, Lan M, Liang S, Wang J, Fan D. Reversal of multidrug resistance of gastric cancer cells by downregulation of ZNRD1 with ZNRD1siRNA. Br J Biomed Sci 2004; 61: 206-10.
17. Labialle S, Gayet L, Marthinet E, Rigal D, Baggetto LG. Transcriptional regulators of the human multidrug resistance 1 gene, recent views. Biochem Pharmacol 2002; 64: 943-8.
18. Potocnik U, Glavac MR, Golouh R, Glavac D. The role of P-glycoprotein (MDR1) polymorphisms and mutations in colorectal cancer. Pflugers Arch 2001; 442: 182-3.
19. Hong L, Qiao T, Han Y, Fan D. ZNRD1 mediates resistance of gastric cancer cells to methotrexate by regulation of IMPDH2 and Bcl-2. Biochem Cell Biol 2006; 84: 199-206.
20. Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002; 2: 277-88.
21. Papadopoulos K. Targeting the bcl-2 family in cancer therapy. Semin Oncol 2006; 33: 449-56.
22. Chang HK, Shin MS, Yang HY. Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells. Biol Pharm Bull 2006; 29: 1597-602.
23. Kennan A, Aherne A, Bowne SJ, Daiger SP, Farrar GJ, Kenna PF, Humphries P. On the role of IMPDH1 in retinal degeneration. Adv Exp Med Biol 2003; 533: 13-8.
24. Hong L, Zhang Y, Han S, Wang J, Pan Y, Liu N, Zhang X, Fan D. Preparation and characterization of a novel monoclonal antibody specific to human ZNRD1 protein. Hybrid Hybridomics 2004; 23: 65-8.
25. Hong L, Zhang Y, Liu N, Liu C, Zhi M, Pan Y, Lan M, Sun L, Fan D. Suppression of the cell proliferation in stomach cancer cells by the ZNRD1 gene. Biochem Biophys Res Commun 2004; 321: 611-6.
26. Hong L, Han Y, Shi R, Shao X, Sun L, Fan D. ZNRD1 gene suppresses cell proliferation through cell cycle arrest in G1 phase. Cancer Biol Ther 2005; 4: 61-5.
27. Hinds PW. A confederacy of kinases: Cdk2 and Cdk4 conspire to control embryonic cell proliferation. Mol Cell 2006; 22: 432-3.
28. Gegas VC, Doonan JH. Expression of cell cycle genes in shoot apical meristems. Plant Mol Biol 2006; 60: 947-61.
29. Guardavaccaro D, Pagano M. Stabilizers and destabilizers controlling cell cycle oscillators. Mol Cell 2006; 22: 1-4.
30. Nakayama KI, Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 2006; 6: 369-81.
31. Davis T, Haughton MF, Jones CJ, Kipling D. Prevention of accelerated cell aging in the Werner syndrome. Ann N Y Acad Sci 2006; 1067: 243-7.
32. Wang MS, Pan Y, Liu N, Guo C, Hong L, Fan D. Overexpression of DARPP-32 in Colorectal Adenocarcinoma. Inter J Clin Prac 2005; 59: 58-61.
33. Clarke PA, Dickson JH, Harris JC, Grabowska A, Watson SA. Gastrin enhances the angiogenic potential of endothelial cells via modulation of heparin-binding epidermal-like growth factor. Cancer Res 2006; 66: 3504-12.
34. Su JL, Yang PC, Shih JY. The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell 2006; 9: 209-23.